KOREAN
Company
Business
R & D
Investors
Company Overview
Welcome Message
Vision & Mission
History
C.I
Careers
Contact Us
Umbilical Cord Blood-derived Stem Cell
Stem Cell Therapy
Stem Cell Conditioned Media
Stem Cell Culture Media
Cell Freezing and Thawing Platform
CDMO
Health & Beauty(H&B) Business
Core Technology
Global R&D Center
Stem Cell GMP Center
Pipeline
Notice
IR
PR
Investors
Notice
IR
Disclosure Information
Stock Information
IR Resource Center
IR Letter & FAQ
PR
Press Release
PR Resource Center
Press Release
Investors
PR
Press Release
[국민일보] 제한적 줄기세포 치료, 희귀·난치병에 희망 줄까 (19.09.03)
2019/09/03 09:35:54
[And 건강] 제한적 줄기세포 치료, 희귀·난치병에 희망 줄까
‘첨생법’ 내년 9월 시행
http://news.kmib.co.kr/article/view.asp?arcid=0924096035&code=14130000&cp=nv
목록으로
[메디컬투데이] 강스템바이오텍, '퓨어스템AD' 3상 결과 연내 발표 예정…"내년 초 허가 신청" (19.09.08)
[청년의사] 강스템바이오텍 '퓨어스템AD' 3상 뚜껑 열린다…기대감↑ (19.09.02)
About Us
Stock Information
Careers
Contact Us
Global R&D Center
Stem Cell GMP Center
Pipeline
TOP
pr : ir_news : view : : /pr/ir_news/view